SCHEMBL6635239

SCHEMBL6635239

O=S(=O)(Cl)c1ccc(OC(F)=C(F)F)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.40
PKM P14618 3/20 0.40
MAPT P10636 3/20 0.40
POLB P06746 2/20 0.40
HSD17B10 Q99714 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
ELANE P08246 2/20 0.37
CA1 P00915 2/20 0.33
CA2 P00918 2/20 0.33
CA12 O43570 1/20 0.33
CA9 Q16790 1/20 0.33
KMT2A Q03164 1/20 0.33
HTT P42858 2/20 0.32
MMP1 P03956 1/20 0.32
MMP2 P08253 1/20 0.32
MMP9 P14780 1/20 0.32
MMP8 P22894 1/20 0.32
MMP13 P45452 1/20 0.32
SOS1 Q07889 1/20 0.32
GAA P10253 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1505805 0.84 PKM (0.57) ALDH1A1PKMMAPTPOLBTDP1
SCHEMBL6635158 0.82 PKM (0.41) ALDH1A1PKMMAPTPOLBELANE
SCHEMBL13922302 0.79 MMP2 (0.42) ALDH1A1PKMMAPTPOLBELANE
SCHEMBL6635236 0.78 NSD2 (0.38) ALDH1A1MAPTHSD17B10TDP1CA1
SCHEMBL4530562 0.78 RAB9A (0.35) ALDH1A1PKMMAPTPOLBHSD17B10
SCHEMBL4871442 0.76 MAPT (0.52) ALDH1A1PKMMAPTPOLBHSD17B10
SCHEMBL3291980 0.76 PKM (0.47) ALDH1A1PKMMAPTPOLBHSD17B10
SCHEMBL28357377 0.75 CA1 (0.38) PKMMAPTPOLBELANECA1
SCHEMBL7038709 0.74 POLB (0.46) ALDH1A1PKMMAPTPOLBHSD17B10
SCHEMBL1279396 0.74 MAPT (0.71) ALDH1A1PKMMAPTPOLBHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1286961-B1 SULFONATED PERFLUOROVINYL FUNCTIONAL MONOMERS 3M INNOVATIVE PROPERTIES CO (US) 2004-05-19 EP disclosed
EP-1286961-A1 SULFONATED PERFLUOROVINYL FUNCTIONAL MONOMERS 3M Innovative Properties Company (US) 2003-03-05 EP disclosed
US-6384167-B2 MECHANICAL PROPERTIES ALONG WITH A DESIRABLE LEVEL OF IONIC CONDUCTIVITY; ION-EXCHANGE MEMBRANES 3M INNOVATIVE PROPERTIES COMPANY 2002-05-07 US disclosed
US-20020007083-A1 Sulfonated perfluorovinyl functional monomers 3M INNOVATIVE PROPERTIES COMPANY 2002-01-17 US disclosed
WO-2001094305-A1 SULFONATED PERFLUOROVINYL FUNCTIONAL MONOMERS 3M INNOVATIVE PROPERTIES COMPANY (US) 2001-12-13 WO disclosed
US-6268532-B1 USED FOR PREPARING SULFONATED OR NON-SULFONATED BLOCK POLYMERS 3M INNOVATIVE PROPERTIES COMPANY 2001-07-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020007083-A1 Sulfonated perfluorovinyl functional monomers AFF2, AFF1, FOS ALDH1A1 1362/4885PKM 3550/4885MAPT 4365/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.